TradingView
TradingMula
22 cze 2015 05:00

Biotech With Value Long

NASDAQ:ARRY
Array Technologies, Inc.NASDAQ

Opis

⋅
NDA submission expected in 2016.
Partnership with AZN and NVS

News: bizjournals.com/denver/blog/boosters_bits/2015/01/array-biopharma-shares-jump-on-novartis-cancer.html?ana=yahoo

Q1 Results- finance.yahoo.com/news/array-biopharma-reports-financial-results-130000096.html
Q3- finance.yahoo.com/news/array-biopharma-reports-financial-results-110000637.html


Multiple phase 3 trials
ovarian, lung, skin(melanoma) cancer
Więcej